BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10991553)

  • 1. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
    Lewinski A; Ferenc T; Sporny S; Jarzab B
    Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
    [No Abstract]   [Full Text] [Related]  

  • 2. The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications.
    Komminoth P
    Virchows Arch; 1997 Jul; 431(1):1-9. PubMed ID: 9247627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Papillary and vesicular carcinoma of the thyroid: diagnostic problems and new data].
    Belleannee G; Trouette H; De Mascarel A
    Ann Pathol; 2000; 20 Suppl():S37-9. PubMed ID: 11261295
    [No Abstract]   [Full Text] [Related]  

  • 4. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.
    Orlandi F; Chiefari E; Caraci P; Mussa A; Gonzatto I; De Giuli P; Giuffrida D; Angeli A; Filetti S
    J Endocrinol Invest; 2001 Jan; 24(1):51-5. PubMed ID: 11227733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic markers in thyroid neoplasia.
    Puxeddu E; Fagin JA
    Endocrinol Metab Clin North Am; 2001 Jun; 30(2):493-513, x. PubMed ID: 11444172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous occurrence of a medullary and a papillary thyroid carcinoma in the same patient.
    Tseleni-Balafouta S; Grigorakis SI; Alevizaki M; Karaiskos C; Davaris P; Koutras DA
    Gen Diagn Pathol; 1997 Jun; 142(5-6):371-4. PubMed ID: 9228264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C cell hyperplasia and medullary microcarcinomas of the thyroid].
    Guyetant S; Saint-Andre JP
    Ann Pathol; 2000; 20 Suppl():S39-44. PubMed ID: 11261296
    [No Abstract]   [Full Text] [Related]  

  • 10. How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape.
    Asa SL
    Mod Pathol; 2001 Mar; 14(3):246-53. PubMed ID: 11266533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective on RET proto-oncogene and thyroid cancer.
    Le HN; Norton JA
    Cancer J; 2000; 6(2):50-7. PubMed ID: 11069217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular, papillary, and "hybrid" carcinomas of the thyroid.
    Castro P; Fonseca E; Magalhães J; Sobrinho-Simões M
    Endocr Pathol; 2002; 13(4):313-20. PubMed ID: 12665649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.
    Reynolds L; Jones K; Winton DJ; Cranston A; Houghton C; Howard L; Ponder BA; Smith DP
    Oncogene; 2001 Jul; 20(30):3986-94. PubMed ID: 11494127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MET receptor tyrosine kinase sequence alterations in differentiated thyroid carcinoma.
    Wasenius VM; Hemmer S; Karjalainen-Lindsberg ML; Nupponen NN; Franssila K; Joensuu H
    Am J Surg Pathol; 2005 Apr; 29(4):544-9. PubMed ID: 15767811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogenes and thyroid tumors].
    Lacroix L; Soria JC; Bidart JM; Schlumberger M
    Bull Cancer; 2005 Jan; 92(1):37-43. PubMed ID: 15689324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The RET gene in thyroid pathology].
    Michiels FM; Billaud M
    Arch Anat Cytol Pathol; 1998; 46(1-2):19-30. PubMed ID: 9754357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of medullary carcinoma of the thyroid.
    Favia G; Lumachi F
    Tumori; 2001; 87(4):S49-51. PubMed ID: 11693822
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
    Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
    Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
    [No Abstract]   [Full Text] [Related]  

  • 20. A ret transgenic mouse model of thyroid carcinogenesis.
    Capen C; Sagartz J
    Lab Anim Sci; 1998 Dec; 48(6):580-3. PubMed ID: 10090080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.